Delayed booster dosing improves human antigen-specific Ig and B

medRxiv - The Preprint Server for Health Sciences

Pathogens, Free Full-Text

PDF) Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection

JCI Insight - Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Single-cell RNA-Seq of antigen-specific B cells from DFx and

Frontiers SARS-CoV-2 Variants, Vaccines, and Host Immunity

Antibodies, Free Full-Text

Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Systems serology computational analyses to define Ig feature sets that

B cell memory: building two walls of protection against pathogens